Biocon announced that with reference to the proposed acquisition of biosimilars assets of Viatris Inc., by Biocon Biologics (BBL), subsidiary of Biocon, BBL has allotted equity shares to Biocon for an amount of Rs. 2,205.63 crore (~US$ 270 Million) on 23 November 2022. Post allotment, Biocons stake in BBL will be 88.85%. Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
